Your browser is no longer supported. Please, upgrade your browser.
Settings
DVA DaVita Inc. daily Stock Chart
DVA [NYSE]
DaVita Inc.
IndexS&P 500 P/E13.66 EPS (ttm)5.82 Insider Own0.60% Shs Outstand124.90M Perf Week-2.03%
Market Cap9.52B Forward P/E12.16 EPS next Y6.54 Insider Trans-19.78% Shs Float118.46M Perf Month-0.48%
Income816.10M PEG1.36 EPS next Q1.29 Inst Own97.20% Short Float5.23% Perf Quarter8.13%
Sales11.49B P/S0.83 EPS this Y28.30% Inst Trans0.24% Short Ratio5.35 Perf Half Y4.77%
Book/sh15.60 P/B5.10 EPS next Y7.62% ROA5.00% Target Price86.95 Perf Year39.84%
Cash/sh11.63 P/C6.84 EPS next 5Y10.05% ROE34.50% 52W Range53.51 - 90.15 Perf YTD6.05%
Dividend- P/FCF4.51 EPS past 5Y6.60% ROI13.00% 52W High-9.84% Beta1.21
Dividend %- Quick Ratio1.80 Sales past 5Y-2.30% Gross Margin31.00% 52W Low51.90% ATR2.66
Employees65000 Current Ratio1.80 Sales Q/Q3.60% Oper. Margin15.10% RSI (14)54.32 Volatility3.33% 2.94%
OptionableYes Debt/Eq4.41 EPS Q/Q153.60% Profit Margin7.80% Rel Volume0.49 Prev Close79.57
ShortableYes LT Debt/Eq4.33 EarningsMay 05 AMC Payout0.00% Avg Volume1.16M Price81.28
Recom2.70 SMA202.53% SMA501.77% SMA2009.44% Volume465,205 Change2.15%
Jan-24-20Upgrade Goldman Neutral → Buy $72 → $97
Nov-07-19Downgrade Raymond James Outperform → Mkt Perform
Oct-25-19Downgrade Wolfe Research Outperform → Peer Perform
Sep-11-19Downgrade William Blair Outperform → Mkt Perform
Jul-26-19Downgrade Robert W. Baird Outperform → Neutral $70 → $65
Jan-08-19Upgrade UBS Sell → Neutral
Jan-03-19Initiated Deutsche Bank Buy $60
Dec-14-18Initiated Barclays Overweight
Nov-28-18Upgrade Raymond James Mkt Perform → Outperform
Nov-16-18Initiated UBS Sell $64
Nov-08-18Downgrade Raymond James Strong Buy → Mkt Perform
Sep-13-18Upgrade JP Morgan Underweight → Neutral
Jan-04-18Upgrade BofA/Merrill Neutral → Buy
Dec-12-17Upgrade Robert W. Baird Neutral → Outperform $63 → $82
Dec-11-17Upgrade Citigroup Neutral → Buy
Dec-07-17Upgrade Raymond James Outperform → Strong Buy
Nov-08-17Reiterated RBC Capital Mkts Sector Perform $64 → $60
Oct-09-17Downgrade JP Morgan Neutral → Underweight
Jun-26-17Downgrade Jefferies Buy → Hold
Dec-13-16Downgrade Robert W. Baird Outperform → Neutral $68 → $69
Jul-10-20 07:19AM  
Jul-09-20 09:48AM  
Jul-08-20 11:40AM  
Jul-07-20 11:30AM  
Jul-06-20 08:15PM  
Jul-03-20 08:26AM  
Jun-23-20 12:39PM  
Jun-17-20 06:17AM  
Jun-16-20 12:20PM  
Jun-11-20 09:19AM  
Jun-10-20 11:40AM  
11:30AM  
09:50AM  
08:19AM  
Jun-04-20 10:32AM  
Jun-02-20 09:24PM  
May-29-20 07:37PM  
11:02AM  
May-28-20 06:17AM  
May-26-20 06:05PM  
11:36AM  
09:06AM  
08:30AM  
May-25-20 11:50AM  
11:40AM  
11:30AM  
May-22-20 06:46PM  
May-16-20 09:02AM  
May-08-20 06:34AM  
May-07-20 04:35PM  
11:50AM  
11:40AM  
11:30AM  
06:17AM  
May-06-20 11:02AM  
10:49AM  
May-05-20 05:15PM  
04:01PM  
03:00PM  
06:05AM  
May-04-20 06:17AM  
May-03-20 06:45AM  
May-01-20 11:20AM  
Apr-29-20 06:33AM  
Apr-28-20 12:33PM  
Apr-22-20 03:36PM  
Apr-20-20 06:14AM  
Apr-16-20 07:37AM  
Apr-13-20 06:23AM  
06:00AM  
05:55AM  
Apr-09-20 10:00AM  
Apr-07-20 09:53AM  
Apr-06-20 04:46PM  
11:50AM  
09:46AM  
Apr-03-20 01:08PM  
11:08AM  
Apr-02-20 04:35PM  
04:04PM  
06:53AM  
06:26AM  
06:17AM  
Apr-01-20 11:40AM  
11:30AM  
09:48AM  
03:19AM  
Mar-31-20 05:50PM  
05:01PM  
10:36AM  
Mar-27-20 08:46AM  
Mar-25-20 05:19PM  
Mar-23-20 05:21PM  
10:15AM  
Mar-20-20 07:47AM  
Mar-18-20 05:45PM  
04:42PM  
Mar-17-20 02:57PM  
Mar-16-20 11:40AM  
11:30AM  
Mar-11-20 11:30AM  
09:01AM  
06:14AM  
Mar-10-20 02:01PM  
08:59AM  
Mar-09-20 10:44AM  
Mar-06-20 08:44AM  
Mar-02-20 08:34AM  
Feb-28-20 11:40AM  
Feb-27-20 11:30AM  
09:43AM  
Feb-26-20 06:14AM  
Feb-24-20 08:56AM  
Feb-20-20 11:53AM  
06:17AM  
Feb-19-20 11:13AM  
10:50AM  
Feb-18-20 09:46AM  
09:39AM  
Feb-17-20 12:00PM  
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services; vascular access services; clinical research programs; physician services; and comprehensive care services. As of December 31, 2019, it provided dialysis and administrative services in the United States through a network of 2,753 outpatient dialysis centers serving approximately 206,900 patients; and operated 259 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 28,700 patients. Further, the company provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was founded in 1994 and is headquartered in Denver, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BERG CHARLESDirectorJun 08Option Exercise81.514,662380,00015,666Jun 10 06:21 PM
DIAZ PAUL JDirectorJun 08Option Exercise81.514,662380,00010,598Jun 10 06:22 PM
NEHRA JOHN MDirectorJun 08Option Exercise81.514,662380,0004,662Jun 10 06:22 PM
GRAUER PETER TDirectorJun 08Option Exercise71.1935,0832,497,46883,790Jun 10 06:23 PM
ROPER WILLIAM LDirectorJun 08Option Exercise81.514,662380,00020,623Jun 10 06:21 PM
Arway Pamela MDirectorJun 08Option Exercise81.514,662380,00023,901Jun 10 06:21 PM
ROPER WILLIAM LDirectorJun 08Sale86.7935730,98315,961Jun 10 06:21 PM
BERG CHARLESDirectorJun 08Sale87.5335731,24911,004Jun 10 06:21 PM
Arway Pamela MDirectorJun 08Sale87.3235731,17419,239Jun 10 06:21 PM
Arway Pamela MDirectorMay 22Sale78.9059947,26119,239May 27 04:05 PM
DIAZ PAUL JDirectorMay 18Sale82.225,763473,8259,986May 19 09:19 PM
THIRY KENT JExecutive ChairmanMay 12Sale80.8962,0005,015,000548,653May 13 08:47 PM
THIRY KENT JExecutive ChairmanMay 11Option Exercise75.42145,52210,975,269283,369May 13 08:47 PM
THIRY KENT JExecutive ChairmanMay 11Sale81.2862,0005,039,391610,653May 13 08:47 PM
THIRY KENT JExecutive ChairmanMay 11Sale81.185,390437,537137,847May 13 08:47 PM
Arway Pamela MDirectorMar 20Sale71.2562544,53119,239Mar 24 06:42 PM
NEHRA JOHN MDirectorMar 02Sale80.747,694621,21454,759Mar 04 07:11 PM
NEHRA JOHN MDirectorFeb 27Sale80.4911,806950,26562,453Feb 28 07:07 PM
NEHRA JOHN MDirectorFeb 26Sale80.9320,0001,618,60074,259Feb 28 07:07 PM